LaVoieHealthScience Honored with Bell Ringer Award for Healthcare Publicity Campaign


Campaign featured signature event, digital content and media relations

BOSTON, MA – June 10, 2016 – LaVoieHealthScience (LHS), an integrated strategic communications agency that is focused on health and life science, announced today it has won a Bell Ringer Merit Award in the healthcare publicity category from the Publicity Club of New England for the agency’s work on behalf of its client, Hydra Biosciences, a biopharmaceutical company focused on the development of novel drugs to treat pain, inflammation, anxiety, and other diseases using its expertise in novel ion channels.

LaVoieHealthScience developed a multi-faceted awareness campaign to highlight the need for better alternatives to opioids for treating pain that would improve efficacy and side effect profiles.  Hydra Biosciences is the world leader in the field of Transient Receptor Potential (TRP) ion channels and is developing medicines that offer improved outcomes with minimal side effects for people with serious diseases and conditions.

The campaign included a signature event called PAIN: a conversation with highly-regarded speakers, digital content, advocacy group outreach, and media relations.  The event drew a standing-room crowd, including several leaders and advocacy groups, to a premier Boston hotel for a networking reception and panel.

“I want to thank our talented team and our client, Hydra Biosciences for their creativity and execution on this important awareness program.  We are honored to be recognized again in 2016 by the Publicity Club of New England,” stated Donna L. LaVoie. “Hydra Biosciences is a great company with leading technology in TRP modulation.  Their commitment to sound science is grounded by an ethical approach to the business of science with the patient in mind.”

Russell Herndon, President and CEO of Hydra Biosciences added, “Our science targets the same cellular pathways that other pain medications do but instead of acting in the brain, like opioids, our compounds work by blocking the pain signals directly in the area where the pain is occurring.  This initiative was  focused on identifying the need for innovation in the treatment of chronic pain while building the support and investment into research and development efforts focused on finding new solutions to this epidemic.  We are honored to receive the recognition for this program with our PR partner, LaVoieHealthScience.”

Since 1969, the Publicity Club of New England’s Bell Ringer Awards have been a symbol of outstanding achievement for New England public relations and communications professionals in every field and industry and across all forms of media.

About LaVoieHealthScience
LaVoieHealthScience partners with leading life science brands to build value for their companies, attract capital, and reach key stakeholders through integrated communications and marketing. The firm provides strategic communications, investor relations and public relations to build recognition and increase sales and value for health science innovations. The agency has received 28 awards over the past seven years in recognition of the work it has done for its health and science industry-leading clients.


Beth Kurth
Vice President, Investor Relations
(617) 374-8800 ext. 106